Literature DB >> 10722567

Activation of intercellular adhesion molecule 1 expression by Helicobacter pylori is regulated by NF-kappaB in gastric epithelial cancer cells.

N Mori1, A Wada, T Hirayama, T P Parks, C Stratowa, N Yamamoto.   

Abstract

Interactions between leukocytes and epithelial cells may play a key role in Helicobacter pylori-associated gastric mucosal inflammation. This process is mediated by various cell adhesion molecules. The present study examined the molecular mechanisms leading to H. pylori-induced epithelial cell intercellular adhesion molecule-1 (ICAM-1; also called CD54) expression. Coculture of epithelial cells with cytotoxin-associated gene pathogenicity island-positive (cag PAI(+)) H. pylori strains, but not with a cag PAI(-) strain or H. pylori culture supernatants, resulted in upregulation of steady-state mRNA levels and cell surface expression of ICAM-1. Coculture with H. pylori induced an increase in luciferase activity in cells which were transfected with a luciferase reporter gene linked to the 5'-flanking region of the ICAM-1 gene. H. pylori activated the ICAM-1 promoter via the NF-kappaB binding site. An inducible nuclear protein complex bound to the ICAM-1 NF-kappaB site and was identified as the NF-kappaB p50-p65 heterodimer. H. pylori induced the degradation of IkappaB-alpha, a major cytoplasmic inhibitor of NF-kappaB, and stimulated the expression of IkappaB-alpha mRNA. Pretreatment of epithelial cells with pyrrolidine dithiocarbamate, which blocks NF-kappaB activation, inhibited H. pylori-induced ICAM-1 expression. THP-1 macrophagic cells, peripheral blood mononuclear cells, and purified neutrophils adhered to H. pylori-infected epithelial cells to a greater extent than to uninfected cells. These results show that H. pylori directly induces expression of ICAM-1 on gastric epithelial cells in an NF-kappaB-dependent manner that may support leukocyte attachment during inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722567      PMCID: PMC97351          DOI: 10.1128/IAI.68.4.1806-1814.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

Review 1.  NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.

Authors: 
Journal:  JAMA       Date:  1994-07-06       Impact factor: 56.272

2.  Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection.

Authors:  L A Noach; N B Bosma; J Jansen; F J Hoek; S J van Deventer; G N Tytgat
Journal:  Scand J Gastroenterol       Date:  1994-05       Impact factor: 2.423

3.  Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients.

Authors:  P Gionchetti; D Vaira; M Campieri; J Holton; M Menegatti; A Belluzzi; E Bertinelli; M Ferretti; C Brignola; M Miglioli
Journal:  Am J Gastroenterol       Date:  1994-06       Impact factor: 10.864

4.  Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines.

Authors:  D Kvale; P Krajci; P Brandtzaeg
Journal:  Scand J Immunol       Date:  1992-06       Impact factor: 3.487

5.  Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

6.  Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes.

Authors:  H W Ziegler-Heitbrock; T Sternsdorf; J Liese; B Belohradsky; C Weber; A Wedel; R Schreck; P Bäuerle; M Ströbel
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

Review 7.  Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation.

Authors:  M J Blaser
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

8.  Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa.

Authors:  J E Crabtree; J I Wyatt; L K Trejdosiewicz; P Peichl; P H Nichols; N Ramsay; J N Primrose; I J Lindley
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

9.  Selective interaction of a subset of interferon-gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells.

Authors:  D C Look; M R Pelletier; M J Holtzman
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

10.  Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family.

Authors:  O Le Bail; R Schmidt-Ullrich; A Israël
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  13 in total

1.  Expression, purification and immuno-characteristics of recombination UreB protein of H.pylori.

Authors:  C Wu; Q M Zou; H Guo; X P Yuan; W J Zhang; D S Lu; X H Mao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  CD54 expression is predictive for lymphatic spread in human gastric carcinoma.

Authors:  Masakazu Yashiro; Takeshi Sunami; Kosei Hirakawa
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

3.  Retracted science and the retraction index.

Authors:  Ferric C Fang; Arturo Casadevall
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

Review 4.  Oxidative stress in Helicobacter pylori-induced gastric cell injury.

Authors:  Hyeyoung Kim
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

5.  Immunoglobulin G1 antibody response to Helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  E Ishii; K Yokota; T Sugiyama; Y Fujinaga; K Ayada; I Hokari; S Hayashi; Y Hirai; M Asaka; K Oguma
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

6.  Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori.

Authors:  Y Hamanaka; M Nakashima; A Wada; M Ito; H Kurazono; H Hojo; Y Nakahara; S Kohno; T Hirayama; I Sekine
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 7.  Cellular and molecular aspects of gastric cancer.

Authors:  Malcolm-G Smith; Georgina-L Hold; Eiichi Tahara; Emad-M El-Omar
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

8.  Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis.

Authors:  M Bajaj-Elliott; P Fedeli; G V Smith; P Domizio; L Maher; R S Ali; A G Quinn; M J G Farthing
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma.

Authors:  Yong-Bin Ding; Guo-Yu Chen; Jian-Guo Xia; Xi-Wei Zang; Hong-Yu Yang; Li Yang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  NF-kappaB activation during acute Helicobacter pylori infection in mice.

Authors:  Richard L Ferrero; Patrick Avé; Delphine Ndiaye; Jean-Christophe Bambou; Michel R Huerre; Dana J Philpott; Sylvie Mémet
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.